{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,14]],"date-time":"2026-01-14T00:11:12Z","timestamp":1768349472639,"version":"3.49.0"},"reference-count":53,"publisher":"Public Library of Science (PLoS)","issue":"4","license":[{"start":{"date-parts":[[2016,4,27]],"date-time":"2016-04-27T00:00:00Z","timestamp":1461715200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Secretaria Nacional de Ciencia y Tecnolog\u00eda (SENACYT)","award":["ECS11-012"],"award-info":[{"award-number":["ECS11-012"]}]},{"DOI":"10.13039\/501100004493","name":"International Atomic Energy Agency","doi-asserted-by":"publisher","award":["PAN-6011"],"award-info":[{"award-number":["PAN-6011"]}],"id":[{"id":"10.13039\/501100004493","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Instituto Conmemorativo Gorgas de Estudios de la Salud","award":["Fondos del Gobierno Nacional de Panam\u00e1"],"award-info":[{"award-number":["Fondos del Gobierno Nacional de Panam\u00e1"]}]}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0154317","type":"journal-article","created":{"date-parts":[[2016,4,27]],"date-time":"2016-04-27T17:43:47Z","timestamp":1461779027000},"page":"e0154317","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":19,"title":["HIV-1 Antiretroviral Drug Resistance Mutations in Treatment Na\u00efve and Experienced Panamanian Subjects: Impact on National Use of EFV-Based Schemes"],"prefix":"10.1371","volume":"11","author":[{"given":"Yaxelis","family":"Mendoza","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Juan","family":"Castillo Mewa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alexander A.","family":"Mart\u00ednez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yamitzel","family":"Zald\u00edvar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"N\u00e9stor","family":"Sosa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Griselda","family":"Arteaga","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Blas","family":"Armi\u00e9n","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christian T.","family":"Bautista","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Claudia","family":"Garc\u00eda-Morales","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daniela","family":"Tapia-Trejo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Santiago","family":"\u00c1vila-R\u00edos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gustavo","family":"Reyes-Ter\u00e1n","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gonzalo","family":"Bello","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Juan M.","family":"Pascale","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"340","published-online":{"date-parts":[[2016,4,27]]},"reference":[{"key":"ref1","author":"M Altfeld","year":"2012"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"481314","DOI":"10.1155\/2013\/481314","article-title":"HIV-1 Genetic Variability and Clinical Implications","volume":"2013","author":"MM Santoro","year":"2013","journal-title":"ISRN microbiology"},{"key":"ref3","unstructured":"UNAIDS. Fact Sheet: The Global HIV\/AIDS epidemic. 2015. Available: <ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"http:\/\/www.unaids.org\/sites\/default\/files\/media_asset\/20150901_FactSheet_2015_en.pdf\" xlink:type=\"simple\">http:\/\/www.unaids.org\/sites\/default\/files\/media_asset\/20150901_FactSheet_2015_en.pdf<\/ext-link>"},{"key":"ref4","unstructured":"Bolet\u00edn estad\u00edstico 2010. Rep\u00fablica de Panam\u00e1: Departamento de Registros y Estad\u00edsticas de Salud. Direcci\u00f3n Nacional de Planificaci\u00f3n. Ministerio de Salud; 2011. p. 113."},{"key":"ref5","unstructured":"Nu\u00f1ez A, Lowe R, Martinez H, Jacobs M. Informe nacional sobre los progresos realizados en el pa\u00eds, Panama, 2014. Per\u00edodo comprendido entre Enero de 2012 y Diciembre de 2013. Rep\u00fablica de Panam\u00e1: Programa Nacional ITS\/VIH\/SIDA: Ministerio de Salud; 2014."},{"key":"ref6","unstructured":"Panama: modern antiretroviral treatment will be available. AIDS Treatment News. 1999 june."},{"issue":"7","key":"ref7","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1001\/jama.286.7.853","article-title":"Availability of HIV Care in Central America","volume":"286","author":"DA Wheeler","year":"2001","journal-title":"JAMA: the journal of the American Medical Association"},{"key":"ref8","unstructured":"Normas para el manejo terap\u00e9utico de las personas con VIH en la Rep\u00fablica de Panam\u00e1: Ministerio de Salud; 2007."},{"key":"ref9","unstructured":"Comisi\u00f3n Nacional para la Prevenci\u00f3n y Control del VIH SIDA C. Plan Estrat\u00e9gico Nacional Multisectorial de ITS VIH y Sida 2009\u20132014. Panama: Programa Nacional de ITS VIH y SIDA. Ministerio de Salud de Panam\u00e1; 2009. 1\u2013108 p."},{"key":"ref10","unstructured":"Normas para el manejo terap\u00e9utico de las personas con VIH en la Rep\u00fablica de Panam\u00e1. Ministerio de Salud; 2011."},{"issue":"9","key":"ref11","doi-asserted-by":"crossref","first-page":"1403","DOI":"10.1097\/QAD.0b013e32835f1db0","article-title":"Adverse events associated with nevirapine and efavirenz-based first-line antiretroviral therapy: a systematic review and meta-analysis","volume":"27","author":"Z Shubber","year":"2013","journal-title":"AIDS"},{"issue":"5","key":"ref12","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1016\/j.meegid.2009.06.013","article-title":"Analysis of HIV-1 pol sequences from Panama: identification of phylogenetic clusters within subtype B and detection of antiretroviral drug resistance mutations","volume":"9","author":"S Ahumada-Ruiz","year":"2009","journal-title":"Infection, genetics and evolution: journal of molecular epidemiology and evolutionary genetics in infectious diseases"},{"issue":"6","key":"ref13","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1590\/S1020-49892011001200025","article-title":"HIV transmitted drug resistance in adult and pediatric populations in Panama","volume":"30","author":"J Castillo","year":"2011","journal-title":"Rev Panam Salud Publica"},{"issue":"1","key":"ref14","doi-asserted-by":"crossref","first-page":"e85153","DOI":"10.1371\/journal.pone.0085153","article-title":"Molecular Epidemiology of HIV-1 in Panama: origin of non-B subtypes in samples collected from 2007 to 2013","volume":"9","author":"Y Mendoza","year":"2014","journal-title":"PloS one"},{"issue":"11","key":"ref15","doi-asserted-by":"crossref","first-page":"1461","DOI":"10.1089\/aid.2008.0153","article-title":"High divergence within the major HIV type 1 subtype B epidemic in Panama","volume":"24","author":"S Ahumada-Ruiz","year":"2008","journal-title":"AIDS research and human retroviruses"},{"issue":"7","key":"ref16","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1097\/QAD.0b013e328351430d","article-title":"Tracing the origin and history of HIV-1 subtype B&apos; epidemic by near full-length genome analyses","volume":"26","author":"Z Li","year":"2012","journal-title":"AIDS"},{"issue":"2","key":"ref17","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/j.virol.2010.03.048","article-title":"Explosive HIV-1 subtype B&apos; epidemics in Asia driven by geographic and risk group founder events","volume":"402","author":"Y Li","year":"2010","journal-title":"Virology"},{"issue":"47","key":"ref18","doi-asserted-by":"crossref","first-page":"18566","DOI":"10.1073\/pnas.0705329104","article-title":"The emergence of HIV\/AIDS in the Americas and beyond","volume":"104","author":"MT Gilbert","year":"2007","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"issue":"3","key":"ref19","doi-asserted-by":"crossref","first-page":"e4814","DOI":"10.1371\/journal.pone.0004814","article-title":"HIV-1 epidemic in the Caribbean is dominated by subtype B","volume":"4","author":"Y Nadai","year":"2009","journal-title":"PloS one"},{"issue":"4","key":"ref20","doi-asserted-by":"crossref","first-page":"e95360","DOI":"10.1371\/journal.pone.0095360","article-title":"Human Immunodeficiency Virus Type 1 (HIV-1) Subtype B Epidemic in Panama Is Mainly Driven by Dissemination of Country-Specific Clades","volume":"9","author":"Y Mendoza","year":"2014","journal-title":"PloS one"},{"issue":"2","key":"ref21","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1177\/135965350801302S04","article-title":"Recommendations for surveillance of transmitted HIV drug resistance in countries scaling up antiretroviral treatment","volume":"13","author":"DE Bennett","year":"2008","journal-title":"Antiviral therapy"},{"issue":"9","key":"ref22","doi-asserted-by":"crossref","first-page":"e72448","DOI":"10.1371\/journal.pone.0072448","article-title":"Phylodynamics of the HIV-1 Epidemic in Cuba","volume":"8","author":"EO Delatorre","year":"2013","journal-title":"PloS one"},{"issue":"7","key":"ref23","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.1093\/molbev\/msn083","article-title":"jModelTest: phylogenetic model averaging","volume":"25","author":"D Posada","year":"2008","journal-title":"Mol Biol Evol"},{"issue":"1","key":"ref24","first-page":"6","article-title":"Update of the Drug Resistance Mutations in HIV-1: March 2013","volume":"21","author":"VA Johnson","year":"2013","journal-title":"Topics in Antiviral Medicine"},{"issue":"3","key":"ref25","doi-asserted-by":"crossref","first-page":"e4724","DOI":"10.1371\/journal.pone.0004724","article-title":"Drug resistance mutations for surveillance of transmitted HIV-1 drug-resistance: 2009 update","volume":"4","author":"DE Bennett","year":"2009","journal-title":"PloS one"},{"key":"ref26","unstructured":"Normas para la atenci\u00f3n integral a las personas con VIH: Ministerio de Salud, Panam\u00e1\/OPS\/OMS; 2006."},{"key":"ref27","unstructured":"PANAM\u00c1, GASTO NACIONAL EN SIDA, 2004\u20132005. Nivel, Flujo de los Recursos y Costos para Enfrentar el VIH\/SIDA. Rep\u00fablica de Panam\u00e1: Programa Nacional de ITS\/VIH\/SIDA y Programa de Acci\u00f3n SIDA para Centroamerica (PASCA); 2006."},{"key":"ref28","unstructured":"WHO. World Health Organization global strategy for the surveillance and monitoring of HIV drug resistance: an update. Available: <ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"http:\/\/www.who.int\" xlink:type=\"simple\">www.who.int<\/ext-link>: World Health Organization; 2012. p. ISBN 978 92 4 150476 8."},{"issue":"10","key":"ref29","first-page":"1469","article-title":"Transmitted drug-resistance in human immunodeficiency virus-infected adult population in El Salvador, Central America","volume":"17","author":"A Holguin","year":"2013","journal-title":"Clin Microbiol Infect"},{"issue":"4","key":"ref30","doi-asserted-by":"crossref","first-page":"e298","DOI":"10.1016\/j.ijid.2009.05.006","article-title":"Antiretroviral drug resistance in HIV-infected patients in Colombia","volume":"14","author":"CA DiazGranados","year":"2010","journal-title":"International journal of infectious diseases: IJID: official publication of the International Society for Infectious Diseases"},{"issue":"11","key":"ref31","doi-asserted-by":"crossref","first-page":"e27812","DOI":"10.1371\/journal.pone.0027812","article-title":"National Prevalence and Trends of HIV Transmitted Drug Resistance in Mexico","volume":"6","author":"S Avila-R\u00edos","year":"2011","journal-title":"PloS one"},{"issue":"4","key":"ref32","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/j.jcv.2010.03.013","article-title":"Transmitted drug resistance and type of infection in newly diagnosed HIV-1 individuals in Honduras","volume":"49","author":"W Murillo","year":"2010","journal-title":"Journal of clinical virology: the official publication of the Pan American Society for Clinical Virology"},{"issue":"6","key":"ref33","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1590\/S1020-49892011001200024","article-title":"Prevalence and patterns of HIV transmitted drug resistance in Guatemala","volume":"30","author":"S Avila-Rios","year":"2011","journal-title":"Rev Panam Salud Publica"},{"issue":"4","key":"ref34","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1089\/aid.2014.0057","article-title":"HIV-1 Drug Resistance Surveillance in Antiretroviral Treatment-Naive Individuals from a Reference Hospital in Guatemala, 2010\u20132013","volume":"31","author":"S Avila-Rios","year":"2015","journal-title":"AIDS research and human retroviruses"},{"key":"ref35","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1186\/1758-2652-12-20","article-title":"Brazilian Network for HIV Drug Resistance Surveillance: a survey of individuals recently diagnosed with HIV","volume":"12","author":"LA Inocencio","year":"2009","journal-title":"Journal of the International AIDS Society"},{"issue":"10","key":"ref36","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1016\/S0969-2126(00)00513-X","article-title":"Structural basis for the resilience of efavirenz (DMP-266) to drug resistance mutations in HIV-1 reverse transcriptase","volume":"8","author":"J Ren","year":"2000","journal-title":"Structure"},{"issue":"4","key":"ref37","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1038\/nsb0495-303","article-title":"Mechanism of inhibition of HIV-1 reverse transcriptase by non-nucleoside inhibitors","volume":"2","author":"R Esnouf","year":"1995","journal-title":"Nature structural biology"},{"issue":"3","key":"ref38","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1016\/j.jmb.2009.03.037","article-title":"Elucidating the inhibition mechanism of HIV-1 non-nucleoside reverse transcriptase inhibitors through multicopy molecular dynamics simulations","volume":"388","author":"A Ivetac","year":"2009","journal-title":"Journal of molecular biology"},{"issue":"1","key":"ref39","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1177\/135965350901400114","article-title":"Compilation and prevalence of mutations associated with resistance to non-nucleoside reverse transcriptase inhibitors","volume":"14","author":"L Tambuyzer","year":"2009","journal-title":"Antiviral therapy"},{"issue":"10","key":"ref40","doi-asserted-by":"crossref","first-page":"4095","DOI":"10.3390\/v6104095","article-title":"Current Perspectives on HIV-1 Antiretroviral Drug Resistance","volume":"6","author":"P Iyidogan","year":"2014","journal-title":"Viruses"},{"issue":"2","key":"ref41","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1006\/jmbi.2000.3823","article-title":"The role of steric hindrance in 3TC resistance of human immunodeficiency virus type-1 reverse transcriptase","volume":"300","author":"HQ Gao","year":"2000","journal-title":"Journal of molecular biology"},{"issue":"10","key":"ref42","doi-asserted-by":"crossref","first-page":"5232","DOI":"10.1128\/JVI.65.10.5232-5236.1991","article-title":"Zidovudine-resistant human immunodeficiency virus selected by passage in cell culture","volume":"65","author":"BA Larder","year":"1991","journal-title":"Journal of virology"},{"issue":"1","key":"ref43","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1002\/jmv.10550","article-title":"Thymidine analogue reverse transcriptase inhibitors resistance mutations profiles and association to other nucleoside reverse transcriptase inhibitors resistance mutations observed in the context of virological failure","volume":"72","author":"AG Marcelin","year":"2004","journal-title":"J Med Virol"},{"issue":"11","key":"ref44","doi-asserted-by":"crossref","first-page":"2410","DOI":"10.1016\/j.biocel.2008.04.007","article-title":"2&apos;-deoxy-4&apos;-C-ethynyl-2-halo-adenosines active against drug-resistant human immunodeficiency virus type 1 variants","volume":"40","author":"A Kawamoto","year":"2008","journal-title":"The international journal of biochemistry & cell biology"},{"issue":"11","key":"ref45","doi-asserted-by":"crossref","first-page":"5500","DOI":"10.1128\/AAC.01195-13","article-title":"In vitro cross-resistance profile of nucleoside reverse transcriptase inhibitor (NRTI) BMS-986001 against known NRTI resistance mutations","volume":"57","author":"Z Li","year":"2013","journal-title":"Antimicrob Agents Chemother"},{"issue":"5","key":"ref46","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1016\/j.coviro.2012.08.006","article-title":"Are subtype differences important in HIV drug resistance?","volume":"2","author":"RJ Lessells","year":"2012","journal-title":"Current opinion in virology"},{"issue":"3","key":"ref47","doi-asserted-by":"crossref","first-page":"e91803","DOI":"10.1371\/journal.pone.0091803","article-title":"Different frequencies of drug resistance mutations among HIV-1 subtypes circulating in China: a comprehensive study","volume":"9","author":"H Sui","year":"2014","journal-title":"PloS one"},{"issue":"8","key":"ref48","doi-asserted-by":"crossref","first-page":"e106045","DOI":"10.1371\/journal.pone.0106045","article-title":"Spatiotemporal dynamics of dissemination of non-pandemic HIV-1 subtype B clades in the Caribbean region","volume":"9","author":"M Cabello","year":"2014","journal-title":"PloS one"},{"issue":"8","key":"ref49","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1111\/hiv.12140","article-title":"Patterns of adherence to antiretroviral therapy and HIV drug resistance over time in the Stratall ANRS 12110\/ESTHER trial in Cameroon","volume":"15","author":"M Meresse","year":"2014","journal-title":"HIV Med"},{"issue":"1","key":"ref50","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1186\/1742-6405-11-9","article-title":"HIV-1 virologic failure and acquired drug resistance among first-line antiretroviral experienced adults at a rural HIV clinic in coastal Kenya: a cross-sectional study","volume":"11","author":"AS Hassan","year":"2014","journal-title":"AIDS research and therapy"},{"issue":"24","key":"ref51","doi-asserted-by":"crossref","first-page":"1984","DOI":"10.1001\/jama.279.24.1984","article-title":"Antiretroviral drug resistance testing in adults with HIV infection: implications for clinical management. International AIDS Society\u2014USA Panel","volume":"279","author":"MS Hirsch","year":"1998","journal-title":"JAMA: the journal of the American Medical Association"},{"issue":"13","key":"ref52","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1056\/NEJM200003303421303","article-title":"Viral load and heterosexual transmission of human immunodeficiency virus type 1. Rakai Project Study Group","volume":"342","author":"TC Quinn","year":"2000","journal-title":"N Engl J Med"},{"issue":"2","key":"ref53","doi-asserted-by":"crossref","first-page":"e87872","DOI":"10.1371\/journal.pone.0087872","article-title":"Expansion of HAART coverage is associated with sustained decreases in HIV\/AIDS morbidity, mortality and HIV transmission: the &quot;HIV Treatment as Prevention&quot; experience in a Canadian setting","volume":"9","author":"JS Montaner","year":"2014","journal-title":"PloS one"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0154317","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,6,18]],"date-time":"2022-06-18T22:24:31Z","timestamp":1655591071000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0154317"}},"subtitle":[],"editor":[{"given":"Giovanni","family":"Maga","sequence":"first","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2016,4,27]]},"references-count":53,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2016,4,27]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0154317","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,4,27]]}}}